Skip to content
  • Add anything here or just remove it...
ImpentriImpentri
  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Contact

Design

Another Print Package

Design

FL3 Print Package

Design

Awesome Pencil Poster

Design

Portfolio typography

Design

Flatsome Poster Print

Design

Magazine

Design

  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Contact

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005142.

This Joint Undertaking receives support from the European Union’s Horizon 2020
research and innovation programme and EFPIA.

IMPENTRI IMI2Follow

IMPENTRI IMI2
Imi2Impentri
14 Dec

Two highly relevant, recent @Nature papers have been published to deepen our understanding of the potential benefit of imatinib for the treatment of #Covid_19:
https://doi.org/10.1038/s41586-020-2901-9
and https://doi.org/10.1038/s41586-020-03065-y

Reply on Twitter 1338417061589086208Retweet on Twitter 1338417061589086208Like on Twitter 1338417061589086208Twitter 1338417061589086208
Imi2Impentri
24 Nov

Team at University of Maryland, Baltimore recently published their protocol for study of oral imatinib in hospitalized adults with COVID-19

https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04819-9#MOESM1

Reply on Twitter 1331196748015001601Retweet on Twitter 1331196748015001601Like on Twitter 1331196748015001601Twitter 1331196748015001601
Imi2Impentri
29 Oct

Really pleased to announce that the CounterCOVID study https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001236-10/NL has today achieved 50% inclusion
#Clinicaltrial #COVID19

Reply on Twitter 1321893154119946243Retweet on Twitter 1321893154119946243Like on Twitter 1321893154119946243Twitter 1321893154119946243
Load More...
Copyright 2021 © Exvastat Ltd
  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Contact
    • WooCommerce not Found